First UKAS accreditation in molecular biology

Almac Diagnostics, a biotechnology company based in Northern Ireland, has become the first company to be awarded accreditation for gene expression microarray and bioinfomatics analysis by the United Kingdom Accreditation Service (UKAS).

Almac Diagnostics, a biotechnology company based in Northern Ireland, has become the first company to be awarded accreditation for gene expression microarray and bioinfomatics analysis by the United Kingdom Accreditation Service (UKAS).

Accreditation by UKAS demonstrates a high level of competence and capability and is important in the management of business risk.

Almac Diagnostics has achieved accreditation by UKAS to ISO/IEC 17025. The company specialises in the application of microarray technology to the diag-nosis and treatment of cancer, utilising the Affymetrix GeneChip platform.

  

Featured Companies

Almac Group (more information, website)